Insider Trading & Ownership - Richardson Peter C

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Richardson Peter C

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-02
Option Award
2024-02-06
4:27 pm
N/A
N/A
Mallinckrodt plcRichardson Peter C
EVP & Chief Scientific Officer
10,258$010,258
(Direct)
View
2023-11-14
Disposition
2023-11-16
4:14 pm
N/A
N/A
Mallinckrodt plcMNKTQRichardson Peter C
EVP & Chief Scientific Officer
75,091$00
(Direct)
View
2023-06-30
Disposition
2023-07-05
6:17 pm
N/A
N/A
Mallinckrodt plcMNKRichardson Peter C
EVP & Chief Scientific Officer
127,861$00
(Direct)
View
2023-04-03
Option Award
2023-04-05
7:05 pm
N/A
N/A
Mallinckrodt plcMNKRichardson Peter C
EVP & Chief Scientific Officer
127,861$0127,861
(Direct)
View
2023-02-02
Option Award
2023-02-03
1:31 pm
N/A
N/A
Mallinckrodt plcMNKRichardson Peter C
EVP & Chief Scientific Officer
75,091$075,091
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:27 pm
N/A
N/A
ANTARES PHARMA INC.ATRSRichardson Peter C
See Remarks
50,613$5.60
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:27 pm
N/A
N/A
ANTARES PHARMA INC.ATRSRichardson Peter C
See Remarks
128,216$00
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:25 pm
N/A
2031-06-10
ANTARES PHARMA INC.ATRSRichardson Peter C
EVP, R&D Chief Medical Officer
69,037$0105,236
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:25 pm
N/A
N/A
ANTARES PHARMA INC.ATRSRichardson Peter C
EVP, R&D Chief Medical Officer
36,199$4.42105,236
(Direct)
View
2021-04-26
Option Award
2021-04-28
8:40 pm
N/A
2031-04-26
ANTARES PHARMA INC.ATRSRichardson Peter C
EVP, R&D Chief Medical Officer
59,179$059,179
(Direct)
View